Government acts on compounding concerns

Compounding exemptions for diabetes medications, Ozempic and Mounjaro, will be removed from 1 October, minister reveals  Compounding pharmacies will be barred from producing replicas of Ozempic (semaglutide) and Mounjaro (tirazapetide) following concerns over the safety, quality and efficacy of products.   Announcing the measure Mark Butler the Minister for Health and Aged Care reported that